Login

Getting Ahead of What Comes Next |Natalie Sandman,General Partner,Spark Capital 00:10:00

Share On Facebook Share On Twitter

Natalie Sandman is the General Partner, Early at Spark Capital.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Najeeb Ghauri, Founder, Chairman, and CEO of NETSOL Technologies Inc., discusses their smart software for car dealers with Sully and Mike.
00:10:00
invests across the Americas|Miguel Armaza,Founding Partner,Gilgamesh Ventures
00:10:00
Five hundred hours of chemotherapy provided OpenText CEO and CTO Mark Barrenechea ample time for reflection during his battle with leukemia.
00:10:00
Dr. Anika Haque Awarded 2023 AXA IM Research Award for Advancing Climate Resilience and Gender Equality
00:10:00
Correlation Ventures The Moneyball of Venture Capital|Anu Pathria,Managing Director, Analytics,Correlation Ventures
00:10:00
Unlocking Prosperity: Joe Pantozzi on Infinite Banking and Wealth Building | Joe Pantozzi , President , Alpha Omega Wealth Management LLC.
00:10:00
Steadfast Growth and Resilience: Nordea's 2023 Recap | Frank Vang-Jensen, CEO, Nordea .
00:10:00
Todd Arthur Bridges Discusses ESG Research and Sustainable Investing at the Sustainable Investment Forum North America 2019
00:10:00
Ammo Inc. CEO Fred Wagenhals on Driving Innovation in the Ammunition Industry | Fred Wagenhal, President, Ammo Inc.
00:10:00
improve the health of people and planet.|Harsh Patel,Co-Founder and Managing Partner,Wireframe Ventures
00:10:00
Dynasty Gold Corp’s Ivy Chong Discusses Exciting Discoveries and Future Plans at Flagship Ontario Project
00:10:00
Driving Research Impact: Insights from Emerald Publishing on the Launch of Impact Services | Emerald Publishing - Pioneers in Academic Research Solutions

© 2026 Nehu